Prof Dr. Piera Di Martino, University “G. d’Annunzio” of Chieti and Pescara, Italy.
Prof.ssa Piera Di Martino, PhD is a renowned figure in pharmaceutical sciences 🧪. She currently serves as Full Professor at the University “G. D’Annunzio” di Chieti e Pescara since 🗓️ November 1, 2021, and was appointed in 🗓️ June 2024 as the ANVUR sub-GEV Coordinator for pharmaceutical and chemical sciences. Her rich academic journey includes more than 25 years in university teaching and research 📚. She was also the founder, CEO, and research leader of the pharmaceutical spin-off RECUSOL 🏢. Di Martino’s scientific influence spans drug formulation, direct compression technologies, and targeted pharmaceutical delivery systems 💊. Her international training in France, specifically in University de Lille II, adds depth to her profile 🌍. Combining academic excellence with innovation and leadership, Prof. Di Martino continues to contribute significantly to pharmaceutical education, research evaluation, and industrial collaboration 🤝.
👩🔬 Profile
Orcid
🎓 Education
Prof. Di Martino earned her degree in Chimica e Technologic Farmaceutiche from the University di Camerino in 🗓️ 1992 with distinction 🎖️. Her thesis on lactose compression marked the beginning of her focus on formulation science 💊. Thanks to a prestigious scholarship 🎓, she spent two years at the University de Lille II in France, where she later earned a Diploma d ’Études Superiors Specializes in Industrial and Galenic Pharmacy 🧴. Her passion led her to pursue a Doctorate in Pharmaceutical Technology 🧪 from the same institution, completing it in 🗓️ 1996 with a thesis on paracetamol polymorphism. Her credentials, recognized by the Italian Ministry of Education 🇮🇹, have provided her with a dual perspective on European pharmaceutical practices and regulation 🌍. This strong educational foundation supports her multifaceted research, teaching, and leadership in academia and applied science 🧠.
🧑🏫 Experience
Prof. Di Martino has a progressive academic trajectory spanning more than two decades 📈. She began her academic career in 🗓️ 1998 as Ricercatrice at the University di Camerino and became Associate Professor from 🗓️ 2011 to 2021 👩🏫. She taught key subjects including drug delivery, industrial pharmaceutical plants, and cosmetic formulation 🧴. In 🗓️ 2013, she co-founded and directed RECUSOL, a pharmaceutical spin-off focused on custom solutions for advanced drug systems 💼. In 🗓️ 2021, she became Full Professor at the University “G. D’Annunzio” 🏛️. Her expertise was formally recognized in 🗓️ 2024 when ANVUR selected her as Coordinator of the sub-GEV Farmaceutico, Technologic e Alimentare 📊. Prof. Di Martino’s experience bridges academia, research management, and public evaluation, making her a crucial figure in shaping Italy’s pharmaceutical science landscape 🇮🇹.
🔬 Research Interests
Prof. Di Martino’s research revolves around drug polymorphism, direct compression technologies, and biotechnological drug delivery systems 💊. Her early work on paracetamol polymorphism provided fundamental insights into solid-state formulation 🌡️. Over the years, she expanded into site-specific delivery, lipid carriers, and formulation of biotechnology drugs 🧫. She also worked on cosmetic-pharmaceutical hybrid products, contributing to innovation in personalized medicine and wellness 🧴✨. Through her leadership of RECUSOL, she has developed practical solutions that translate lab results into real-world pharmaceutical products 🚀. Her research integrates academic knowledge, industry needs, and regulatory considerations, aiming to create effective, patient-friendly drug systems 🤝. She is currently involved in reviewing and guiding national research outputs through her ANVUR coordinator role 📝. Her goal remains consistent: advancing pharmaceutical science while ensuring real-world applicability and innovation in healthcare delivery systems 🏥.
🏆 Awards and Recognition
Prof. Di Martino has earned numerous honors 🏅. Her appointment by ANVUR in 2024 as Coordinator of sub-GEV Farmaceutico, Tecnologico e Alimentare for the VQR 2020–2024 marked a national recognition of her expertise in research quality assessment 📈. She was the founder and CEO of RECUSOL, a spin-off recognized for translating academic pharmaceutical innovations into industry solutions 🚀. Her contributions to academic teaching, research evaluation, and institutional governance have led to consistent commendations from the University di Camerino and University “G. D’Annunzio” 🏛️. She has received invited speaker roles, research grants, and faculty awards, reflecting her influence across multiple domains 🌐. As a trusted evaluator, she sits on national panels, ensuring high scientific integrity and quality output 📑. These accolades affirm her lasting impact on pharmaceutical sciences, both in Italy and internationally 🌍.
📚 Publication Top Notes
Hyaluronic Acid-Based Nanosystems for CD44 Mediated Anti-Inflammatory and Antinociceptive Activity
Evaluation of Physicochemical and Microbial Properties of Extracts from Wine Lees Waste of Matelica’s Verdicchio and Their Applications in Novel Cosmetic Products
Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties
PLGA Nanoparticles Grafted with Hyaluronic Acid to Improve Site-Specificity and Drug Dose Delivery in Osteoarthritis Nanotherapy
Chemical, Antioxidant, and Antimicrobial Properties of the Peel and Male Flower By-Products of Four Varieties of Punica granatum L. Cultivated in the Marche Region for Their Use in Cosmetic Products
🧩 Conclusion
Prof. Piera Di Martino’s career is a blend of academic brilliance, research innovation, and institutional leadership 🎓. From her academic foundation in Camerino and Lille to her rise as a full professor and ANVUR appointee, she exemplifies excellence 🌟. Her unique contributions span teaching, research, entrepreneurship, and national evaluation policy 🧠. Through her role at RECUSOL, she brought lab innovation into real-world application, showcasing how academic research can serve society 🚀. Her leadership in strategy, education, and science policy cements her status as a national resource in pharmaceutical science 🇮🇹. Prof. Di Martino continues to shape Italy’s research landscape with integrity, depth, and vision 👏.